Director dealing

Summary by AI BETAClose X

Professor Sir Christopher Evans, Chief Scientific Officer, purchased 197,500 ordinary shares in EDX Medical on-market on 6 and 9 November 2026 at an average price of 7.5 pence per share (aggregate cost ≈ £14,812.50), increasing his holding to 136,417,793 shares, representing 31.62% of the issued share capital; trades executed on XLON:AIMX at prices of £0.074 and £0.075 per share.

Disclaimer*

UK 100

Latest directors dealings